Medicare Enrolled
Dr. Byron Dubow, M.D.
Urology Physician · Templeton, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dubow from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dubow?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dubow
Dr. Byron Dubow is an urology physician in Templeton, CA, with 10 years of NPI registration. Based on federal Medicare data, Dr. Dubow performed 62,681 Medicare services across 3,793 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dubow received a total of $5,204 from 44 pharmaceutical and/or device companies across 214 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dubow is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 10 years in practice
▲ Top 3% volume in CA
$5,204 industry payments
Medicare Practice Summary
Medicare Utilization ↗62,681
Medicare services
Top 3% in CA for urology physician
3,793
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~6,268 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone undecanoate injection (Aveed) An injection of testosterone undecanoate, a form of testosterone hormone. This procedure involves administering the medication via injection. |
41,250 | $1 | $3 |
| Injection, degarelix, 1 mg | 6,800 | $3 | $7 |
| Denosumab injection (Prolia/Xgeva) | 3,600 | $19 | $35 |
| BCG treatment for bladder cancer | 2,700 | $2 | $5 |
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
2,600 | $5 | $11 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,234 | $94 | $240 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
975 | $2 | $15 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
309 | $117 | $305 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
306 | $9 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
261 | $64 | $170 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 225 | $132 | $358 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
222 | $198 | $450 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
170 | $12 | $45 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
146 | $29 | $72 |
| Implantable tissue marker, each A small marker is implanted into tissue to serve as a reference point for future medical imaging or procedures. |
91 | $24 | $45 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
84 | $49 | $275 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
83 | $140 | $335 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
72 | $0 | $5 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
68 | $72 | $210 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
58 | $93 | $260 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
53 | $197 | $470 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
42 | $47 | $215 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
41 | $47 | $150 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
32 | $19 | $146 |
| Prostate radiation therapy device placement A device is placed in the prostate to facilitate radiation therapy. This procedure involves positioning the device to aid in the delivery of radiation treatment. |
31 | $117 | $280 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
30 | $135 | $360 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
28 | $102 | $245 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
23 | $58 | $170 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
22 | $90 | $847 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
20 | $334 | $735 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
19 | $64 | $130 |
| Insertion of temporary bladder tube | 17 | $35 | $225 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
17 | $0 | $5 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
15 | $585 | $1,500 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
14 | $321 | $800 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
12 | $30 | $95 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
11 | $260 | $650 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
88.0% medium
11.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,204
Total received (2018-2024)
Avg $743/year across 7 years
Top 32% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
214
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,078 (97.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$126 (2.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,434
2023
$1,352
2022
$1,080
2021
$577
2020
$109
2019
$66
2018
$586
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$258
ABBVIE INC.
$191
Astellas Pharma US Inc
$160
PFIZER INC.
$108
Myriad Genetic Laboratories, Inc.
$102
Axonics, Inc.
$94
Dendreon Pharmaceuticals LLC
$87
ACCORD HEALTHCARE, INC.
$79
SUN PHARMACEUTICAL INDUSTRIES INC.
$65
Antares Pharma, Inc.
$52
COLOPLAST CORP
$42
Teleflex LLC
$33
Bayer Healthcare Pharmaceuticals Inc.
$30
Merck Sharp & Dohme LLC
$28
Janssen Biotech, Inc.
$27
PROGENICS PHARMACEUTICALS, INC.
$24
Endo Pharmaceuticals Inc.
$21
Endo USA, Inc.
$19
Ferring Pharmaceuticals Inc.
$16
Top 3 companies account for 42.4% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$481
Myriad Genetic Laboratories, Inc.
$446
Sumitomo Pharma America, Inc.
$409
BOSTON SCIENTIFIC CORPORATION
$345
Janssen Biotech, Inc.
$283
Dendreon Pharmaceuticals LLC
$276
TOLMAR Pharmaceuticals, Inc.
$263
PFIZER INC.
$254
ABBVIE INC.
$253
Coloplast Corp
$249
AbbVie Inc.
$184
PROCEPT BioRobotics Corporation
$157
Axonics, Inc.
$156
Foundation Medicine, Inc.
$127
Endo Pharmaceuticals Inc.
$95
Palette Life Sciences, Inc.
$92
Amgen Inc.
$83
Allergan, Inc.
$82
AstraZeneca Pharmaceuticals LP
$81
ACCORD HEALTHCARE, INC.
$79
Teleflex LLC
$66
SUN PHARMACEUTICAL INDUSTRIES INC.
$65
Boston Scientific Corporation
$60
Antares Pharma, Inc.
$52
Merck Sharp & Dohme LLC
$51
Philips Electronics North America Corporation
$45
Merck Sharp & Dohme Corporation
$44
COLOPLAST CORP
$42
UroGen Pharma, Inc.
$42
UROVANT SCIENCES INC
$41
Smith+Nephew, Inc.
$34
Verity Pharmaceuticals Inc.
$30
Bayer Healthcare Pharmaceuticals Inc.
$30
Tolmar, Inc.
$25
PROGENICS PHARMACEUTICALS, INC.
$24
Blue Earth Diagnostics Limited
$24
Janssen Scientific Affairs, LLC
$23
AngioDynamics, Inc.
$21
Endo USA, Inc.
$19
Bayer HealthCare Pharmaceuticals Inc.
$17
Pacira Pharmaceuticals Incorporated
$16
Ferring Pharmaceuticals Inc.
$16
Becton, Dickinson and Company
$13
SRS Medical Systems, Inc.
$12
Top 3 companies account for 25.7% of all-time payments
Associated products mentioned in payments ›
(4145) Dynacad Prostate · (4504) Uronav Add On · ADSTILADRIN · AQUABEAM ROBOTIC SYSTEM · AVEED · Altis · Axonics · BOTOX · BRAC CDx · CAMCEVI · CFN CHLORAPREP · ELIGARD · ERLEADA · Exparel · FOUNDATIONONE · FOUNDATIONONE LIQUID CDX · GEMTESA · GENERAL THERAPIES · GENERAL KIDNEY STONE DISEASE · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · MYRISK · Myrbetriq · NANOKNIFE · Nubeqa · PERISTEEN · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · SPACEOAR VUE · SPEEDICATH · STRAVIX PL · SpaceOAR VUE System - 10mL · SpeediCath · Titan · Trelstar · UROLIFT · UroCuff · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xtandi · YONSA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
12
Per 100K population
4.3
County median income
$93,398
Nearest hospital
ADVENTIST HEALTH TWIN CITIES
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dubow is a mixed practice specialist, with above-average Medicare volume (top 3% in CA), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dubow experienced with testosterone undecanoate injection (aveed)?
Based on Medicare claims data, Dr. Dubow performed 41,250 testosterone undecanoate injection (aveed) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dubow receive payments from pharmaceutical companies?
Yes. Dr. Dubow received a total of $5,204 from 44 companies across 214 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dubow's costs compare to other urology physicians in Templeton?
Dr. Dubow's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dubow) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Templeton
Browse urology physicians in Templeton ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Myriad Genetic Laboratories, Inc. Payments to Doctors
See all physicians who received payments from Myriad Genetic Laboratories, Inc.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology